The Réjuve medical device quickly increases fiber bonds in the tissue matrix to provide a mechanically stronger long-lasting tear-resistant tissue. Thus, it could become a replacement or adjunct to common surgical procedures such as discectomies, spinal fusions, and spinal implants.

Réjuve is an injectable crosslinking device that mechanically strengthens and quickly stabilizes the disc. This micro-invasive procedure can be performed on an outpatient basis and should be complete with just one injection treatment. 

Introducing Réjuve- Your Spine Rejuvenated


The Réjuve medical device is designed to be effective in treating large avascular (no direct blood supply) load-supporting tissues like the spinal disc.


A key to Réjuve's effectiveness is the device's ability to promote crosslinking of fibrous proteins including collagen, which rejuvenates the spinal disk area.

Disc degeneration is happening to all of us; for most of us it can cause pain!

  • Annulus tissue becomes delaminated, fissured, or micro-damaged

  • Spinal joint becomes unstable

  • Disc bulges against nerves


Réjuve medical device reduces pain by:

  • Strengthening annulus against tearing and delamination

  • Increasing joint stability

  • Reducing disc bulge

Réjuve: Effectively Protected

There are twenty-five (25) issued patents to date with additional under review. Réjuve is also supported by thirty-two (32) peer-reviewed papers.

Intralink-Spine, Inc. has received ISO 13485:2016 certification for its Quality Management System (QMS) following review by its notified body, MedCert GmbH. ISO 13485:2016 is an internationally recognized quality standard specific to the medical device industry and signifies Intralink-Spine’s commitment to the highest level of medical device quality controls and meeting customer and international regulatory expectations.  

© 2020 by Intralink-Spine Inc. 

Attention: The IDSD is not available for sale in the US, Canada, or EU. Clinical studies are being conducted In Australia.